瑞替加滨
RETIGABINE;2-AMINO-4-(4-FLUORBENZYLAMINO)-1-ETHOXYCARBONYLAMINOBENZENE;D2312;N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic Acid Ethyl Ester;D 23129;Retigabin;Ethyl [2-amino-4-[[(4-fluorophenyl)methyl]amino]phenyl]carbamate;RetigabineDiscontinued See: R189051;Ezogabine impurity;Retigabine See also:;Retigabine solution;Retigabine See also: R189051 (HCl salt); D-23129, Ezogabine, N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester;mL in Acetonitrile) See also: R189051 (HCl salt);mL in Acetonitrile)See also:R189051 (HCl salt);D-23129;Ezogabine;Retagabine;Retigabine API;Retigabine Base;Potiga;Trobalt;Ezogabine [USAN];Ethyl 2-amino-4-((p-fluorobenzyl)amino)carbanilate;D 20443;12G01I6BBU;C16H18FN3O2;ethyl N-[2-amino-4-[(4-fluorophenyl)methylamino]phenyl]carbamate;Ethyl (2-amino-4-(((4-fluorophenyl)methyl)amino)phenyl)carbamate;Retigabine [INN];N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid;N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic acid ethyl ester;2-Amino-4-(4-fluorbenzylamino)-1-ethoxycarbonylaminobenzene;CHEBI:68584;FBX;AWD21-360;DEA No. 2779;KE-0201;RETIGABINE [MART.];Ezogabine (USAN);FT-0601527;Retigabine (INN);Retigabine, >=98% (HPLC);GW582892X;[2-Amino-4-[[(4-fluorophenyl)methyl]amino]phenyl]-carbamate;PCOBBVZJEWWZFR-UHFFFAOYSA-N;GKI 841;GW 582892X;GKE-841;BCP0726000089;RTG;AMY18466;BDBM50143558;ADD-230001;Retigabine, analytical standard;SCHEMBL20835;UNII-12G01I6BBU;DB04953;WAY-143841;s4733;BCP04194;GTPL2601;NCGC00346739-01;RETIGABINE [WHO-DD];Retigabine (1.0 mg/mL in Acetonitrile);ethyl 2-amino-4-(4-fluorobenzylamino)phenylcarbamate;ethyl N-[2-azanyl-4-[(4-fluorophenyl)methylamino]phenyl]carbamate;ZINC00016154;150812-12-7;XEN-496;CCG-267503;ethyl {2-amino-4-[(4-fluorobenzyl)amino]phenyl}carbamate;AE3 - Newer Anti-epileptic drug mixtures 3;NS00040686;HSDB 8171;n-[2-amino-4-(4-fluorobenzylamino)-phenyl]carbamic acid ethyl ester;N03AX21;Retigabine,D2312, D-23129;RETIGABINE [EMA EPAR];AKOS015895311;AC-6908;D09569;Q-101418;A809076;DTXSID40164615;MFCD04307735;EZOGABINE [VANDF];NCGC00346739-06;XEN496;CS-0990;NCGC00346739-05;EZOGABINE [ORANGE BOOK];Carbamic acid, (2-amino-4-(((4-fluorophenyl)methyl)amino)phenyl)-, ethyl ester;Potiga (TN);Q2146170;CHEMBL41355;GW-582892X;AWD-21360;N-(2-Amino-4-(4-fluorobenzylamino)-phenyl) carbamic acid ethyl ester;HMS3748I09;HMS3885L20;WAY 143841;AW21-360;CARBAMIC ACID, (2-AMINO-4-(((4-FLUORO-PHENYL)METHYL)AMINO)PHENYL)-ETHYL ESTER;N-[2-amino-4-[(4-fluorophenyl)methylamino]phenyl]carbamic acid ethyl ester;ethyl N-(2-amino-4-{[(4-fluorophenyl)methyl]amino}phenyl)carbamate;HY-15471;[2-Amino-4-(4-fluoro-benzylamino)-phenyl]-carbamic acid ethyl ester;EX-A2203;EZOGABINE [MI];Retigabine;ethyl (2-amino-4-((4-fluorobenzyl)amino)phenyl)carbamate;N-(2-amino-4-[fluorobenzylamino]-phenyl) carbamic acid;N-(2-amino-4-(4-fluorobenzylamino)-phenyl)carbamic acid ethylester;Potiva